세계의 바이오인포매틱스 플랫폼 시장 보고서(2025년)
Bioinformatics Platform Global Market Report 2025
상품코드 : 1760061
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,527,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,434,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,341,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오인포매틱스 플랫폼 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 8.1%의 CAGR로 143억 5,000만 달러 규모에 이를 것으로 예상됩니다. 예측 기간 동안의 성장은 맞춤형 의료에 대한 수요 증가, 생물학적 및 유전체 데이터의 양 증가, 신약 개발에 대한 투자 증가, 클라우드 기반 바이오인포매틱스 솔루션의 채택 증가, 농업 및 식량 안보에 대한 바이오인포매틱스의 적용 확대에 기인할 것으로 예상됩니다. 예측 기간 동안 주요 동향으로는 유전체학 및 정밀의료의 발전, AI 및 머신러닝 알고리즘의 개선, 클라우드 기반 바이오인포매틱스 솔루션의 통합, 멀티오믹스 데이터 분석, 임상 진단 및 바이오마커 탐색 기술 채택 등이 있습니다.

맞춤형 의료의 채택 확대가 향후 몇 년간 바이오인포매틱스 플랫폼 시장의 성장을 견인할 것으로 예상됩니다. 맞춤형 의료는 개인의 유전적 프로필, 생활습관, 환경적 요인에 따라 치료 및 예방 전략을 조정하는 것입니다. 이 접근법은 질병과 관련된 유전적 돌연변이를 정확하게 식별할 수 있는 유전체 기술의 발전으로 인해 더욱 탄력을 받고 있으며, 이를 통해 보다 효과적인 치료를 할 수 있습니다. 맞춤형 의료에 대한 수요가 증가함에 따라 첨단 바이오인포매틱스 플랫폼의 필요성이 더욱 커지고 있습니다. 이러한 플랫폼은 대량의 유전체 및 임상 데이터를 분석 및 해석하고 맞춤형 치료 계획을 수립하는 데 필수적이기 때문입니다. 예를 들어, 2024년 2월 미국 비영리단체인 개인맞춤의료연합(PMC)은 FDA가 2023년 희귀질환 환자를 위한 16개의 새로운 맞춤형 치료제를 승인했다고 보고했습니다. 이에 따라 맞춤형 의료의 채택이 증가하여 바이오인포매틱스 플랫폼 시장의 성장을 촉진할 것으로 예상됩니다.

바이오인포매틱스 플랫폼 시장의 주요 기업들은 멀티오믹 데이터 매핑 플랫폼과 같은 첨단 솔루션을 개발하여 복잡한 질병과 병태생리에 대한 보다 정확한 인사이트와 깊은 이해를 제공하고 있습니다. 이러한 플랫폼은 유전체학, 전사체학, 단백질체학, 대사체학 등 여러 생물학적 계층의 데이터를 통합하고 분석하여 복잡한 생물학적 과정에 대한 종합적인 관점을 제시합니다. 예를 들어, 미국에 본사를 둔 생명공학 기업 BioSkryb Genomics는 2023년 2월 BaseJumper 바이오인포매틱스 플랫폼을 발표했습니다. 이 플랫폼은 대규모 단일 세포 정보학을 간소화하여 ResolveOME 시스템을 강화하여 ResolveOME에서 생성된 멀티옴 데이터(DNA, RNA, 단백질)의 효율적인 정리 및 매핑을 가능하게 하고, 데이터 해석을 간소화하여 데이터 해석을 간소화합니다. 또한, 동적 필터링과 일련의 시각화 도구를 제공하여 다양한 분야의 연구자들이 복잡한 데이터세트를 쉽게 분석 및 시각화할 수 있도록 돕습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

제36장 부록

ksm
영문 목차

영문목차

A bioinformatics platform is a comprehensive software system that combines various tools, algorithms, and databases to support the analysis, interpretation, and management of biological data. These platforms often enable collaborative research by integrating multidisciplinary knowledge and resources to advance progress in healthcare, drug development, and personalized medicine.

Key bioinformatics platforms include sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural and functional analysis platforms, and more. A sequence analysis platform is a software or toolset designed to process, analyze, and interpret biological sequences, such as DNA, RNA, or protein data. It is used in genomics, proteomics, drug discovery, personalized medicine, and other fields by a range of end-users, including pharmaceutical and biotechnology companies, academic and research institutions, healthcare providers, and others.

The bioinformatics platform market research report is one of a series of new reports from The Business Research Company that provides bioinformatics platform market statistics, including bioinformatics platform industry global market size, regional shares, competitors with a bioinformatics platform market share, detailed bioinformatics platform market segments, market trends and opportunities, and any further data you may need to thrive in the bioinformatics platform industry. This bioinformatics platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioinformatics platform market size has grown strongly in recent years. It will grow from $9.69 billion in 2024 to $10.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to a heightened focus on systems biology and integrative omics, increasing collaborations between research institutes and biotech companies, rising awareness of the benefits of bioinformatics, a growing number of bioinformatics-enabled startups, and expanding government initiatives and funding in genomics research.

The bioinformatics platform market size is expected to see strong growth in the next few years. It will grow to $14.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth during the forecast period can be attributed to the increasing demand for personalized medicine, the rising volume of biological and genomic data, growing investments in drug discovery and development, the increasing adoption of cloud-based bioinformatics solutions, and the expanding application of bioinformatics in agriculture and food security. Key trends in the forecast period include advancements in genomics and precision medicine, improvements in AI and machine learning algorithms, integration of cloud-based bioinformatics solutions, multi-omics data analysis, and the adoption of technology in clinical diagnostics and biomarker discovery.

The growing adoption of personalized medicine is expected to drive the growth of the bioinformatics platform market in the coming years. Personalized medicine tailors treatment and prevention strategies based on an individual's genetic profile, lifestyle, and environmental factors. This approach is gaining momentum due to advances in genomic technologies, which allow for the precise identification of genetic variations associated with diseases, enabling more targeted and effective treatments. The increasing demand for personalized medicine is fueling the need for advanced bioinformatics platforms, as these platforms are crucial for analyzing and interpreting large volumes of genomic and clinical data to develop customized treatment plans. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from the six approvals in 2022. As a result, the rising adoption of personalized medicine is expected to boost the growth of the bioinformatics platform market.

Leading companies in the bioinformatics platform market are developing advanced solutions, such as multiomic data mapping platforms, to provide more accurate insights and a deeper understanding of complex diseases and conditions. These platforms integrate and analyze data from multiple biological layers, including genomics, transcriptomics, proteomics, and metabolomics, to offer a comprehensive view of complex biological processes. For example, in February 2023, BioSkryb Genomics, a US-based biotechnology company, launched the BaseJumper Bioinformatics Platform. This platform enhances the ResolveOME system by simplifying large-scale single-cell informatics. It enables efficient organization and mapping of multiomic data (DNA, RNA, and protein) generated by ResolveOME, streamlining data interpretation. The platform also provides dynamic filtering and a set of visualization tools, enabling researchers across various fields to easily analyze and visualize complex datasets.

In April 2023, Excelra, an India-based informatics company, acquired BISC Global for an undisclosed amount. This acquisition creates a global leader in consulting-driven bioinformatics by combining expertise in artificial intelligence, machine learning, and omics, as well as next-generation sequencing data analysis. The merger aims to accelerate bioinformatics innovation and deliver enhanced benefits to customers from both organizations. BISC Global is a Germany-based provider of bioinformatics platforms.

Major players in the bioinformatics platform market are F. Hoffmann-La Roche Ltd., International Business Machines Corporation, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Dassault Systemes SE, Agilent Technologies Inc., Illumina Inc., Wuxi NextCODE, PerkinElmer Inc., Bio-Rad Laboratories Inc., Waters Corporation, Bruker Corporation, Partek Incorporated, Qiagen N.V., NeoGenomics Laboratories Inc., Genedata AG, ID Business Solutions, DNAnexus Inc., Sophia Genetics S.A., Accelrys Inc., DNASTAR Inc., Gene Codes Corporation, BGI Group, Fios Genomics Ltd., and Golden Helix Inc.

North America was the largest region in the bioinformatics platform market in 2024. The regions covered in bioinformatics platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bioinformatics platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioinformatics platform market consists of revenues earned by entities by providing services such as transcriptomics services, data integration and visualization, custom pipeline development, and training and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioinformatics platform market also includes sales of biological databases, cloud computing platforms, genome annotation tools, and clinical interpretation tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioinformatics Platform Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioinformatics platform market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bioinformatics platform ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioinformatics platform market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Bioinformatics Platform Market Characteristics

3. Bioinformatics Platform Market Trends And Strategies

4. Bioinformatics Platform Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bioinformatics Platform Growth Analysis And Strategic Analysis Framework

6. Bioinformatics Platform Market Segmentation

7. Bioinformatics Platform Market Regional And Country Analysis

8. Asia-Pacific Bioinformatics Platform Market

9. China Bioinformatics Platform Market

10. India Bioinformatics Platform Market

11. Japan Bioinformatics Platform Market

12. Australia Bioinformatics Platform Market

13. Indonesia Bioinformatics Platform Market

14. South Korea Bioinformatics Platform Market

15. Western Europe Bioinformatics Platform Market

16. UK Bioinformatics Platform Market

17. Germany Bioinformatics Platform Market

18. France Bioinformatics Platform Market

19. Italy Bioinformatics Platform Market

20. Spain Bioinformatics Platform Market

21. Eastern Europe Bioinformatics Platform Market

22. Russia Bioinformatics Platform Market

23. North America Bioinformatics Platform Market

24. USA Bioinformatics Platform Market

25. Canada Bioinformatics Platform Market

26. South America Bioinformatics Platform Market

27. Brazil Bioinformatics Platform Market

28. Middle East Bioinformatics Platform Market

29. Africa Bioinformatics Platform Market

30. Bioinformatics Platform Market Competitive Landscape And Company Profiles

31. Bioinformatics Platform Market Other Major And Innovative Companies

32. Global Bioinformatics Platform Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioinformatics Platform Market

34. Recent Developments In The Bioinformatics Platform Market

35. Bioinformatics Platform Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기